Scottish medical device maker Current Health has secured the US Food and Drug Administration (FDA) clearance for its artificial intelligence (AI) enabled, wearable, remote patient monitoring device.
Current has been designed as a wireless solution for automatic and continuous monitoring of patients. The device is developed using a real-time physiological data set.
Go deeper with GlobalData
It has been embedded with the company’s algorithms to analyse data and contextual patient information continuously and deliver actionable and proactive insights into the user’s health.
Current can also be integrated with other devices to collect additional metrics, determining patient-specific digital therapeutics and recommendations.
The device is intended to enable early intervention. The company added that healthcare providers will be able to use the device for proactive care delivery to improve patient outcomes.
In addition, the monitoring device is expected to minimise hospital readmissions in cases of patients whose condition deteriorates post therapy. Unnecessary hospital readmissions cost more than $40bn per year in the US.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe device has been deployed at Mount Sinai Brooklyn in the US for earlier detection of patient deterioration and to enhance healthcare outcomes.
Mount Sinai Brooklyn president Scott Lorin said: “Current’s continuous and proactive monitoring platform has the potential to alert us to patient deterioration faster and give our team data insights they can act on earlier.”
The remote monitoring device has already secured approval for use in the European Union (EU). Healthcare providers in the UK are currently using the solution in a post-acute setting.
The Dartford and Gravesham NHS Trust’s Hospital at Home team has used Current to remotely monitor patients after discharge, which is said to have led to a 22% decrease in home visits by the staff.
In addition, the organisation reported lower hospital readmissions and emergency department visits.
Current Health believes that the availability of its wearable device can be expanded from hospitals to at-home use in the future.
Remote health monitoring has been growing in popularity as both patients and healthcare professionals want health to be monitored outside of clinical settings. The tech can aid people with numerous conditions but is mostly used for monitoring heart conditions and diabetes.
